Janux Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
10955 Vista Sorrento Parkway, Suite 200, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/6/2024, 04:25 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Nov 4, 2024
SC 13G Report SC 13G Oct 23, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G/A Report Feb 9, 2024
SC 13G/A Report SC 13G/A Feb 1, 2024
SC 13G Report SC 13G Jul 10, 2023
SC 13G Report SCHEDULE 13G May 30, 2023
SC 13G/A Report SC 13G/A Feb 10, 2023
SC 13G/A Report JHG PLC OWNS <5% Feb 9, 2023
SC 13G/A Report Feb 9, 2023
SC 13G Report Jan 23, 2023
SC 13G Report JANUS HENDERSON GROUP PLC OWNS 5.8% OF JANUX THERAPEUTICS Feb 14, 2022
SC 13G Report SC 13G Feb 11, 2022
SC 13G Report Jan 10, 2022
SC 13G Report SC 13G Jun 25, 2021